@article{SulimanMustafaKruegeretal.2016, author = {Suliman, Salwa and Mustafa, Kamal and Krueger, Anke and Steinm{\"u}ller-Nethl, Doris and Finne-Wistrand, Anna and Osdal, Tereza and Hamza, Amani O. and Sun, Yang and Parajuli, Himalaya and Waag, Thilo and Nickel, Joachim and Johannessen, Anne Christine and McCormack, Emmet and Costea, Daniela Elena}, title = {Nanodiamond modified copolymer scaffolds affects tumour progression of early neoplastic oral keratinocytes}, series = {Biomaterials}, volume = {95}, journal = {Biomaterials}, doi = {10.1016/j.biomaterials.2016.04.002}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-188287}, pages = {11-21}, year = {2016}, abstract = {This study aimed to evaluate the tumorigenic potential of functionalising poly(LLA-co-CL) scaffolds. The copolymer scaffolds were functionalised with nanodiamonds (nDP) or with nDP and physisorbed BMP-2 (nDP-PHY) to enhance osteoinductivity. Culturing early neoplastic dysplastic keratinocytes (DOK\(^{Luc}\)) on nDP modified scaffolds reduced significantly their subsequent sphere formation ability and decreased significantly the cells' proliferation in the supra-basal layers of in vitro 3D oral neoplastic mucosa (3D-OT) when compared to DOK\(^{Luc}\) previously cultured on nDP-PHY scaffolds. Using an in vivo non-invasive environmentally-induced oral carcinogenesis model, nDP scaffolds were observed to reduce bioluminescence intensity of tumours formed by DOK\(^{Luc}\) + carcinoma associated fibroblasts (CAF). nDP modification was also found to promote differentiation of DOK\(^{Luc}\) both in vitro in 3D-OT and in vivo in xenografts formed by DOKLuc alone. The nDP-PHY scaffold had the highest number of invasive tumours formed by DOK\(^{Luc}\) + CAF outside the scaffold area compared to the nDP and control scaffolds. In conclusion, in vitro and in vivo results presented here demonstrate that nDP modified copolymer scaffolds are able to decrease the tumorigenic potential of DOK\(^{Luc}\), while confirming concerns for the therapeutic use of BMP-2 for reconstruction of bone defects in oral cancer patients due to its tumour promoting capabilities.}, language = {en} } @article{MumcuogluSiverinoTabiszetal.2017, author = {Mumcuoglu, Didem and Siverino, Claudia and Tabisz, Barbara and Kluijtmans, Bas and Nickel, Joachim}, title = {How to use BMP-2 for clinical applications? A review on pros and cons of existing delivery strategies}, series = {Journal of Translational Science}, volume = {3}, journal = {Journal of Translational Science}, number = {5}, doi = {10.15761/JTS.1000195}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-158678}, year = {2017}, abstract = {No abstract available.}, language = {en} }